{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:44:12Z","timestamp":1787010252208,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>Intraepithelial fallopian tube neoplasia is thought to be a precursor lesion to high-grade serous carcinoma of the M\u00fcllerian adnexae, particularly in women with BRCA1 or BRCA2 mutations. This association has led to recommendations to assess fallopian tubes for intraepithelial atypia. However, the diagnostic reproducibility of a diagnosis of intraepithelial neoplasia is unclear. In this study, 2 gynecologic pathologists independently evaluated sections of fallopian tubes from a sample of women (N=198, 623 slides) undergoing salpingectomy. A total of 101 (54%) women were undergoing risk-reducing salpingo-oophorectomy. Pathologists were blinded to patient histories and prior diagnoses. Pathologists rendered one of three diagnoses for each slide: \u201cnegative for fallopian tube intraepithelial neoplasia (FTIN),\u201d \u201cindeterminate for FTIN,\u201d or \u201cdefinite for FTIN.\u201d Cases that were considered by histology definite for FTIN or suspicious for FTIN were stained with p53 and Ki67. Pathologists agreed on the diagnosis of \u201cdefinite for FTIN\u201d 61.5% of the time. There was no agreement on any cases for the diagnosis of \u201cindeterminate for FTIN.\u201d Fifteen \u201cindeterminate for FTIN\u201d and 12 \u201cdefinite for FTIN\u201d cases were stained with p53 and Ki67. Two of the \u201cindeterminate\u201d cases (13%) had p53-positive foci. Five of the \u201cdefinite\u201d cases had p53-positive foci. In 3 of the other 8 \u201cdefinite\u201d cases, there was obvious carcinoma present, but the carcinoma did not stain with p53, suggesting a possible null phenotype. We propose that immunostains should only be used to aid in the diagnosis of FTIN in cases with indeterminate histology. The use of p53 immunohistochemistry in cases that were considered \u201cdefinite for FTIN\u201d by histology was minimally helpful, and in fact often served to further confuse the diagnosis.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000604","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T06:57:38Z","timestamp":1556348258000},"page":"261-269","source":"Crossref","is-referenced-by-count":13,"title":["An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions"],"prefix":"10.1097","volume":"39","author":[{"given":"Marie E.","family":"Perrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Reder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergay N.","family":"Agoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle L.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy J.","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn P.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Kilgore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 10","key":"R1-20230824","doi-asserted-by":"crossref","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann Oncol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","article-title":"Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations","volume":"132","author":"Conner","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PAT.0b013e32835f2264","article-title":"Precursors and pathogenesis of ovarian carcinoma","volume":"45","author":"Lim","year":"2013","journal-title":"Pathology"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1701-2163(15)30659-9","article-title":"The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift","volume":"36","author":"Reade","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0b013e3181ecdee1","article-title":"A pathologist\u02bcs road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube","volume":"17","author":"Mehrad","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/126295","article-title":"Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics","volume":"2010","author":"Gross","year":"2010","journal-title":"J Oncol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/gyn.2017.0012","article-title":"Carcinosarcoma arising from serous tubal intraepithelial carcinoma","volume":"33","author":"Hoffman","year":"2017","journal-title":"J Gynecol Surg"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PGP.0b013e318264aece","article-title":"Ovarian carcinosarcoma associated with bilateral tubal intraepithelial carcinoma: a case report","volume":"32","author":"Brustmann","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ygyno.2014.07.084","article-title":"A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers","volume":"134","author":"Cass","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PGP.0b013e31824cbeb4","article-title":"Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Kuhn","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/pin.12419","article-title":"Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer","volume":"66","author":"Nishida","year":"2016","journal-title":"Pathol Int"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/a-0611-5167","article-title":"Opportunistic salpingectomy at the time of benign laparoscopic hysterectomy: assessment of possible complications and histopathological p53-signatures","volume":"78","author":"Chene","year":"2018","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4132\/jptm.2016.06.17","article-title":"Comparison of the classical method and SEE-FIM protocol in detecting microscopic lesions in fallopian tubes with gynecological lesions","volume":"52","author":"Koc","year":"2018","journal-title":"J Pathol Transl Med"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ajcp\/aqx062","article-title":"Epitope preservation methods for tissue microarrays","volume":"148","author":"Andeen","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Medica"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/jnci\/djx263","article-title":"Reported incidence and survival of fallopian tube carcinomas: a population-based analysis from the North American Association of Central Cancer Registries","volume":"110","author":"Trabert","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2015.09.018","article-title":"Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): a comprehensive review","volume":"139","author":"Patrono","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","article-title":"Serous tubal intraepithelial carcinoma (STIC) \u2013 clinical impact and management","volume":"16","author":"Weinberger","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clon.2018.03.036","article-title":"Outcome and prognostic impact of surgical staging in serous tubal intraepithelial carcinoma: a cohort study and systematic review","volume":"30","author":"Van der Hoeven","year":"2018","journal-title":"Clin Oncol"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/GRF.0000000000000316","article-title":"Management of preinvasive lesions","volume":"60","author":"Patrono","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.5858\/arpa.2017-0231-RA","article-title":"Serous tubal intraepithelial carcinoma or not? Metastases to fallopian tube mucosa can masquerade as in situ lesions","volume":"141","author":"Singh","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","volume":"41","author":"Kommoss","year":"2017","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T21:41:24Z","timestamp":1692826884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000604","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}